Abbott India Q3 net profit rises at Rs 117 crore, revenue rises to Rs 947 crore
Abbott India had posted a net profit of Rs 115.39 crore for the corresponding period of the previous financial year, Abbott India said in a filing to BSE.
New Delhi: Drug firm Abbott India on Friday reported a marginal rise of 1.43 per cent in its net profit to Rs 117.05 crore for the third quarter ended December 31, 2018.
The company had posted a net profit of Rs 115.39 crore for the corresponding period of the previous financial year, Abbott India said in a filing to BSE.
Read Also: DOP directs NPPA to refix the ceiling price of Gentamicin based on Abbot application
Revenue from operations of the company stood at Rs 947.65 crore for the quarter under consideration, as against Rs 881.49 crore for the same period year ago.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd